6/2010
vol. 27
Case report Allergic and toxic reaction caused by fragrances – a case report
Magdalena Czarnecka-Operacz
,
Post Dermatol Alergol 2010; XXVII, 6: 511–514
Online publish date: 2010/12/29
Get citation
Introduction Fragrances are the principal allergens of cosmetic products and together with preservatives are among the top 5 most frequent contact allergens [1, 2]. There are approximately 5000 aromatic compounds currently used in the perfume industry and it is estimated that a single perfume may contain from 50 to 300 molecules, which create characteristic scents [3]. Exposure to perfumed molecules is multiple and practically permanent. Fragrance molecules are found not only in cosmetic products, but also in a wide variety of manufactured products, including household domestic and food products (where they are used as flavours) and even in topical medicaments (where they maintain antiseptic properties) [3, 4]. It is estimated that an average adult uses nine cosmetics daily, while more than 25% of women use 15 or more [5]. Adverse reactions to cosmetics constitute an increasing clinical problem. Although they are observed often, the real frequency is not exactly known. Most individuals who experience mild reactions, such as erythema or stinging sensations, simply change to another product. There is agreement about the percentage of 1 to 2 in terms of sensitization to cosmetics in the general population, accounting for 6-14% of all cases of allergic contact dermatitis [1, 6].
The contemporary diagnostics of contact allergy to fragrances is based on patch tests with fragrance mix. Fragrance mix I (FM I) is a mixture of eight aromatic substances (one natural compound, oak moss absolute, and other synthetic fragrances) and identifies 70-80% of fragrance allergy cases [6]. According to the recommendations of the European Society of Contact Dermatitis (1 March 2008) the European baseline series was enlarged by adding new substances: fragrance mix II (FM II) and Lyral (hydroxyisohexyl 3-cyclohexene carboxaldehyde) [7]. Case report A 66-year-old patient was hospitalized in the Department of Dermatology, University of Medical Sciences in Poznań in order to diagnose and apply treatment of papuloerythematous lesions of the skin in the region of the lower and upper lip. Primary skin lesions (increasing erythema and oedema) and recurrent stinging sensations had been observed already one month earlier. The patient complained of “hypersensitivity” to creams for everyday use and difficulty in proper selection of cosmetics. No coexisting diseases were detected.
During hospitalization in our clinic all performed laboratory tests were within the normal range. The direct examination for Demodex folliculorum within the skin of the face was negative. Results of skin prick tests performed with main aeroallergens were negative. Patch tests were performed with the Standard European Set of contact allergens (Chemotechnique, Sweden). The first reading after 48 h was positive (+++) with FM I, whereas in the area with Lyral and FM II single blisters containing clearly visible light yellow liquid were observed (fig. 1). After 72 h no variation in the test result was recorded (fig. 2). Readings were performed according to ICDRG guidelines. Discussion Cosmetics, according to their definition, are generally perceived as safe and well tolerated. In fact, even products labelled as hypoallergenic can cause adverse reactions. Murphy et al. described a 25-year-old woman with exacerbation of eczema, which was related to the use of two new skin products promoted as hypoallergenic and preservative free, ideally suited to atopic individuals. A detailed study revealed the presence of two preservatives, methyldibromoglutaronitrile and formaldehyde [8]. Preservatives are second to fragrances as a cause of allergic contact dermatitis. The other responsible chemicals are phenylenediamine, lanolin, and Balsam of Peru.
The range of undesirable effects related to the use of cosmetics includes contact dermatitis (both allergic and irritant), photosensitivity, phototoxic dermatitis, contact urticaria and pigmentary disturbances. Among adverse reactions to fragrances, the most common clinical manifestation seen by dermatologists is allergic contact dermatitis [9, 10]. Investigators from Brazil determined the frequency of dermatoses associated with the use of cosmetics. In a group of 176 patients, the main condition triggered by these products was contact dermatitis, observed in 49 cases, and a diagnosis of allergic contact dermatitis was made only in 4 patients. The other dermatoses reported as a side-effect of cosmetic use were seborrhoeic dermatitis aggravated by use of the product, alopecia and dermatitis caused by inappropriate use of cosmetics [11].
Fragrances are usually number 2 after nickel sulfate among patients with positive patch test results [9, 10]. Patch testing with FM I has been widely used as an indicator of fragrance contact allergy since the late 1970s (Larsen 1977) [2, 3, 12]. However, Larsen et al. noted that as much as 33% of fragrance sensitivity may be missed if only those eight recommended substances are tested. Based on European multicentre studies, additional markers of fragrance allergy were added to the European baseline patch series: fragrance mix 2 (FM II) and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HMPCC) or Lyral. Systemic investigation has shown that FM II detects patients sensitive to fragrances missed by FM I [7]. Furthermore, the ability to diagnose fragrance allergy is now increased and can reach 95% [3]. Frosch et al. reported positive results with FM II in 2.9% of tested patients with the concentration of 14%, and additionally he found that approximately 1/3 of the patients reacting to FM II were negative to FM I [13].
FM II contains citral, farnesol, coumarin, Lyral, citronellol and cinnamal at 14.0% in petrolatum. The most common of this set of allergens is Lyral followed by farnesol [7]. Lyral is the trade name of a mixture of 4-(4-hydroxy-4-methyl-pentyl)-3-cyclohexene carboxaldehyde (70%) and 3-(4-hydroxy-4-methyl-pentyl)-3-cyclohexene carboxaldehyde (30%), manufactured by International Flavors & Fragrances (IFF, New York, USA) [6]. HMPCC as a synthetic fragrance is commonly used in consumer products and has a characteristic sweet scent [6]. Patch test concentration of Lyral in FM II is 2.5%, while as an individual ingredient test concentration is 5%. The prevalence of positive reaction to Lyral in European studies is between 1.5% and 3%, whereas in a USA study it was only 0.4% [1, 14]. This difference is attributed to the presence of Lyral in higher concentrations in deodorants in the EU compared with the USA. In a Danish study 25 popular perfume products were investigated in terms of the content of fragrance allergens, including HMPCC. The concentration of Lyral reached a maximum of 0.2%, which is 10-fold higher than the maximum tolerable concentration considered safe by the EU Scientific Committee [15]. According to the International Fragrance Association (IFRA) the recommended maximal concentration in both leave-on and rinse-off products is 1.5% (2003) [14].
The face is a classic area of involvement for contact dermatitis caused by fragrances. However, lesions of the neck as well as armpits and behind the ears should also arouse suspicion of an allergy to perfumes [3, 10]. Because of the more intense use of scented products by women, men are much less affected. However, in men eczematous eruptions may be provoked by the use of aftershave lotions, appearing within the beard area and adjacent parts of the neck. Although the characteristic age of fragrance allergy is the mid-forties, in adolescents such sensitivity is also diagnosed [2, 4]. A Danish study performed on a group of 1146 12-16 year old children revealed positive reactions to the fragrance mix in 1.6% of girls and 2.1% of boys [16].
In the presented case report we observed allergic (to FM I) and toxic reactions (to FM II and Lyral) to fragrances. Taking into account available data concerning this issue, no blisters in the area with FM II and Lyral were detected previously, and no mentions of coexistence of allergic and toxic reactions in the same case report were recorded. We suppose that in the area with FM II the blister formation was provoked by the Lyral. As mentioned above, in FM II all compounds are in 14% concentration (with Lyral at 2.5%), while Lyral, as a separate allergen, is in 5% concentration. With regard to the case presented here, it may be suggested that there is a group of patients who react in a toxic way to standardized concentrations of allergens used in patch tests and that these concentrations may be too high. According to Larsen, the mix was originally formulated in 16% in petrolatum (2% for each hapten). Due to the frequently observed irritant reactions the concentration was decreased in 1984 to 8% (1% for each hapten) [9]. To identify the concentration of Lyral that is sufficiently low not to cause an allergic reaction in patients with proven sensitization, researchers from Germany conducted repeated open application test (ROAT) in 64 patients. The concentration of Lyral safe for sensitized people should be in the range of 0.009-0.027% (0.18-0.34%), depending on the product type [17].
To sum up, the current case report was presented due to the frequent occurrence of allergic and toxic contact reaction caused by fragrances observed in recent years. Because of the continuously increasing number of new fragrance molecules (due to developments in the fragrance industry, and changing fashion), there is a need to conduct further investigations on this subject to enlarge the set of tested allergens. It is also worthwhile to study their concentration to select patients with allergic and toxic reactions. References 1. Nardelli A, Carbonez A. Frequency of and trends in fragrance allergy over a 15-year period. Contact Dermatitis 2008; 58: 134-41.
2. Johansen JD. Fragrance contact allergy. Am J Clin Dermatol 2003; 4: 789-98.
3. Guiraud-Pons A, Vigan M. Allergies and cosmetics. Allergic dermatitis. The UCB Institute of Allergy 2004; 52-72.
4. Ortiz K, Yiannias J. Contact dermatitis to cosmetics, fragrances, and botanicals. Dermatol Ther 2004; 17: 264-71.
5. Nigam PK. Adverse reactions to cosmetics and methods of testing. Indian J Dermatol Venereol Leprol 2009; 75: 10-8.
6. Gimenez-Arnau A, Gimenez-Arnau E, Serra-Baldrich E, et al. Principles and methodology for identification of fragrance allergens in consumer products. Contact Dermatitis 2002; 47:, 345-52.
7. Bruze M, Andersen KE, Goossens A; ESCD; EECDRG. Recommendation to include fragrance mix and hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) in the European baseline patch test series. Contact Dermatitis 2008; 58: 129-33.
8. Murphy LA, White IR, Rastogi SC. Is hypoallergenic a credible term? Clin Exp Dermatol 2004; 29: 325-7.
9. de Groot AC, Frosch PJ. Adverse reactions to fragrances. A clinical review. Contact Dermatitis 1997; 36: 57-86.
10. Kieć-Świerczyńska M. Co nowego w alergologii kontaktowej? Post Dermatol Alergol 2009; 26: 344-6.
11. Duarte I, Campos Lage AC. Frequency of dermatoses associated with cosmetics. Contact Dermatitis 2007; 56: 211-3.
12. Rudzki E, Rebandel P, Jaworski E. Alergia kontaktowa na składowe perfum: izoeugenol i eugenol. Post Dermatol Alergol 2004; 21: 177-9.
13. Frosch PJ, Pirker C, Rastogi SC, et al. Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix. Contact Dermatitis 2005; 52: 207-15.
14. Braendstrup P, Johansen JD. Hydroxisohexyl 3-cyclohexene carboxaldehyde (Lyral) is still a frequent allergen. Contact Dermatitis 2008; 59: 187-8.
15. Rastogi S, Johansen JD. Selected important fragrance sesitizers in perfumes-current exposures. Contact Dermatitis 2007; 56: 201-4.
16. Mortz CG, Lauritisen JM. Contact allergy and allergic contact dermatitis in adolescents; prevalence measures and associations. Acta Derm Venereol 2002; 82: 352-8.
17. Schnuch A, Uter W, Dickel H, et al. Quantitative patch and repeated open application testing in hydroxyisohexyl 3-cyclohexene carboxaldehyde sensitive-patients. Contact Dermatitis 2009; 61: 152-62.
Copyright: © 2010 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
|